NEW YORK (GenomeWeb) – Luxembourg's Advanced Biological Laboratories (ABL) announced Tuesday that it has signed an agreement granting Thermo Fisher Scientific international distribution rights for ABL's ViroScore Suite and DeepChek virology sequencing analysis software.

Under the terms of the agreement, Thermo Fisher has the rights to distribute the software around the world, excluding Spain, China, and Japan.

Financial and other details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.